Arcutis Biotherapeutics Ownership | Who Owns Arcutis Biotherapeutics?
Arcutis Biotherapeutics Ownership Summary
Arcutis Biotherapeutics is owned by 99.15% institutional investors, 1.94% insiders. Jennison associates is the largest institutional shareholder, holding 9.93% of ARQT shares. Polar Capital Biotech S Inc is the top mutual fund, with 4.82% of its assets in Arcutis Biotherapeutics shares.
ARQT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arcutis Biotherapeutics | 99.15% | 1.94% | -1.09% |
| Sector | Healthcare Stocks | 279.19% | 10.58% | -189.76% |
| Industry | Biotech Stocks | 63.97% | 10.68% | 25.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Jennison associates | 12.34M | 9.93% | $171.89M |
| Suvretta capital management | 11.40M | 9.17% | $158.79M |
| Rubric capital management lp | 10.97M | 8.82% | $152.77M |
| Blackrock | 8.62M | 7.76% | $80.19M |
| Blackrock funding, inc. /de | 9.15M | 7.36% | $127.44M |
| Frazier life sciences management | 8.79M | 7.11% | $81.70M |
| Polar capital | 7.38M | 5.93% | $102.77M |
| Vanguard group | 6.44M | 5.18% | $89.72M |
| State street | 4.95M | 3.98% | $68.96M |
| Morgan stanley | 3.97M | 3.22% | $36.95M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pivotal bioventure partners investment advisor | 2.12M | 19.95% | $29.54M |
| Tejara capital | 886.84K | 8.09% | $12.35M |
| Suvretta capital management | 11.40M | 5.41% | $158.79M |
| Frazier life sciences management | 8.79M | 3.82% | $81.70M |
| Lion point capital, lp | 46.30K | 3.38% | $644.96K |
| Rubric capital management lp | 10.97M | 1.96% | $152.77M |
| Stempoint capital lp | 500.97K | 1.74% | $6.98M |
| Cormorant asset management, lp | 1.82M | 1.40% | $25.42M |
| Privium fund management b.v. | 325.71K | 1.03% | $4.54M |
| Myda advisors | 200.00K | 0.70% | $2.79M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 2.79M | 0.01% | 2.57M |
| Blackrock | 8.62M | 0.00% | 1.96M |
| Point72 asset management | 1.75M | 0.05% | 1.51M |
| Cercano management | 1.26M | 0.44% | 1.26M |
| Millennium management | 2.31M | 0.02% | 1.16M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | - | - | -1.36M |
| Braidwell lp | - | - | -1.30M |
| Stempoint capital lp | 500.97K | 1.74% | -1.28M |
| Bain capital life sciences investors | - | - | -1.03M |
| Franklin resources | 3.31M | 0.01% | -941.10K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Cercano management | 1.26M | 0.44% | 1.26M | $17.49M |
| Driehaus capital management | 1.10M | 0.13% | 1.10M | $15.28M |
| Simplify asset management | 742.30K | 0.51% | 742.30K | $10.34M |
| Norges bank | 532.79K | 0.00% | 532.79K | $7.42M |
| Privium fund management b.v. | 325.71K | 1.03% | 325.71K | $4.54M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Colonial trust advisors | -100.00 |
| Byrne asset management | -100.00 |
| Bessemer group | -110.00 |
| True wealth design | -111.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 246 | 13.36% | 124,963,282 | -3.01% | 99 | 0.92% | 127 | 16.51% | 81 | 22.73% |
| Dec 31, 2024 | 214 | 9.74% | 120,033,596 | -6.58% | 96 | 0.90% | 107 | 3.88% | 66 | 29.41% |
| Sep 30, 2024 | 194 | 1.57% | 128,485,475 | 1.57% | 103 | 0.98% | 104 | -3.70% | 51 | -7.27% |
| Jun 30, 2024 | 191 | 13.02% | 126,499,025 | 1.37% | 102 | 0.81% | 108 | -0.92% | 55 | 44.74% |
| Mar 31, 2024 | 169 | 24.26% | 124,792,426 | 23.24% | 112 | 0.94% | 109 | 21.11% | 38 | 46.15% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Polar Capital Biotech S Inc | 5.75M | 4.82% | -250.00K |
| Vanguard US Total Market Shares ETF | 3.59M | 3.03% | 492.10K |
| Vanguard Total Stock Mkt Idx Inv | 3.44M | 2.89% | 97.99K |
| Jennison SMid Cap Core Equity | 3.09M | 2.60% | - |
| PGIM Jennison Small Company A | 3.09M | 2.59% | - |
| iShares Russell 2000 ETF | 2.76M | 2.31% | 1.35K |
| Jennison Health Sciences Equity | 2.27M | 1.91% | -465.50K |
| PGIM Jennison Health Sciences Z | 2.27M | 1.90% | - |
| SPDR® S&P Biotech ETF | 1.81M | 1.52% | 2.34K |
| Franklin Biotechnology Discv A(acc)USD | 1.69M | 1.41% | -23.94K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 04, 2025 | Heron Patrick J | - | Buy | $25.18K |
| Jun 05, 2025 | Heron Patrick J | - | Buy | $5.07K |
| May 28, 2025 | Matsuda Masaru | See Remarks | Sell | $24.81K |
| May 21, 2025 | Heron Patrick J | - | Buy | $34.42K |
| May 22, 2025 | Heron Patrick J | - | Buy | $34.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 8 | 9 |
| 2025 Q1 | - | 18 |
| 2024 Q4 | 3 | 14 |
| 2024 Q3 | - | 9 |
| 2024 Q2 | - | 10 |
ARQT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools